TIGIT and colon adenocarcinoma: Given the potential interaction between TIGIT and PD-1, we then assessed the antitumor effects of combined inhibition of TIGIT and PD-1 signals using a xenograft B6J mouse tumor model derived from MC38 colon adenocarcinoma cells.